These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 26385119)
1. Posterior Reversible Encephalopathy Syndrome in Early-Stage Breast Cancer. Ladwa R; Peters G; Bigby K; Chern B Breast J; 2015; 21(6):674-7. PubMed ID: 26385119 [TBL] [Abstract][Full Text] [Related]
2. Recurrent posterior reversible encephalopathy syndrome after chemotherapy in hematologic malignancy-posterior reversible encephalopathy syndrome can strike twice!!! Roy S; Gandhi AK; Jana M; Julka PK J Cancer Res Ther; 2014; 10(2):393-6. PubMed ID: 25022403 [TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy syndrome (PRES) after combination chemotherapy for lymphoma. Ramachandran A; Klein R Am J Ther; 2014; 21(5):e137-42. PubMed ID: 23075577 [TBL] [Abstract][Full Text] [Related]
4. Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML). Battipaglia G; Avilia S; Morelli E; Caranci F; Perna F; Camera A Ann Hematol; 2012 Aug; 91(8):1327-8. PubMed ID: 22237936 [No Abstract] [Full Text] [Related]
9. Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review. Femia G; Hardy TA; Spies JM; Horvath LG Asia Pac J Clin Oncol; 2012 Jun; 8(2):115-22. PubMed ID: 22524570 [TBL] [Abstract][Full Text] [Related]
10. [Reversible posterior leukoencephalopathy post-chemotherapy with carboplatin and paclitaxel]. Jamelot M; Fontanilles M; Vaschalde Y Bull Cancer; 2019 Dec; 106(12):1191-1195. PubMed ID: 31472945 [No Abstract] [Full Text] [Related]
11. Syndrome of inappropriate anti-diuretic hormone secretion secondary to carboplatin after docetaxel-carboplatin-trastuzumab combination for early stage HER-2 positive breast cancer. Turner N; Stewart J; Barnett F; White S Asia Pac J Clin Oncol; 2012 Sep; 8(3):e9-e11. PubMed ID: 22897880 [TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES). Janjua TK; Hassan M; Afridi HK; Zahid NA BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978604 [TBL] [Abstract][Full Text] [Related]
13. Posterior reversible encephalopathy syndrome (PRES) after treatment with oxaliplatin and 5-fluorouracil. Truman N; Nethercott D Clin Colorectal Cancer; 2013 Mar; 12(1):70-2. PubMed ID: 22917935 [No Abstract] [Full Text] [Related]
14. Early Recognition and Management of Posterior Reversible Encephalopathy Syndrome: A Newly Recognized Complication in Patients Receiving Tyrosine Kinase Inhibitors. Przybylyski A; Esper P Clin J Oncol Nurs; 2016 Jun; 20(3):305-8. PubMed ID: 27206297 [TBL] [Abstract][Full Text] [Related]
15. Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects! Khurana A; Dasanu CA J Oncol Pharm Pract; 2015 Dec; 21(6):443-50. PubMed ID: 25013187 [TBL] [Abstract][Full Text] [Related]
16. Platinum compounds in the treatment of advanced breast cancer. Martín M Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413 [TBL] [Abstract][Full Text] [Related]